EKF Diagnostics (LON:EKF) Shares Down 7% – Time to Sell?

EKF Diagnostics Holdings plc (LON:EKF)’s share price traded down 7% on Friday . The stock traded as low as GBX 23.60 ($0.31) and last traded at GBX 26 ($0.35). 2,281,890 shares were traded during trading, an increase of 404% from the average session volume of 453,091 shares. The stock had previously closed at GBX 27.95 ($0.37).

EKF Diagnostics Trading Down 7.0%

The company’s fifty day moving average price is GBX 29.18 and its two-hundred day moving average price is GBX 26.63. The company has a quick ratio of 1.77, a current ratio of 4.60 and a debt-to-equity ratio of 0.34. The company has a market cap of £116.76 million, a price-to-earnings ratio of 19.26 and a beta of 0.57.

EKF Diagnostics (LON:EKF) last released its quarterly earnings results on Tuesday, September 16th. The company reported GBX 0.43 EPS for the quarter. EKF Diagnostics had a return on equity of 7.03% and a net margin of 9.37%. Research analysts expect that EKF Diagnostics Holdings plc will post 2.2987842 earnings per share for the current year.

EKF Diagnostics Company Profile

EKF is an AIM-listed global diagnostics business focussed on:

? Point-of-Care analysers in the key areas of Hematology and Diabetes

? Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.

EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.